Monoclonal Antibody Treatments

Let’s Prevent Hospitalizations and Consider Monoclonal Antibody Treatments In November, 2020, FDA issued Emergency Use Authorizations (EUA) for two monoclonal antibody products. An EUA is different than full FDA approval in that it is issued in emergent circumstances, usually without the comprehensive studies required for full licensure of the product. Because of this limited data,…

Alternative Care Sites

As the SARS-CoV2 virus has surged across the US in the last month, EWP has seen increasing pressure on hospitals who are hard pressed to accommodate patients due to limitations in staff, space, and equipment. Although many facilities have invoked sophisticated resource sparing strategies, they are rapidly approaching the need to utilize crisis standards of…